1. Home
  2. NYT vs RGEN Comparison

NYT vs RGEN Comparison

Compare NYT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYT
  • RGEN
  • Stock Information
  • Founded
  • NYT 1851
  • RGEN 1981
  • Country
  • NYT United States
  • RGEN United States
  • Employees
  • NYT N/A
  • RGEN N/A
  • Industry
  • NYT Newspapers/Magazines
  • RGEN Medical/Dental Instruments
  • Sector
  • NYT Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • NYT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • NYT 8.6B
  • RGEN 8.0B
  • IPO Year
  • NYT N/A
  • RGEN N/A
  • Fundamental
  • Price
  • NYT $55.45
  • RGEN $127.47
  • Analyst Decision
  • NYT Buy
  • RGEN Buy
  • Analyst Count
  • NYT 5
  • RGEN 12
  • Target Price
  • NYT $56.40
  • RGEN $170.40
  • AVG Volume (30 Days)
  • NYT 1.4M
  • RGEN 685.0K
  • Earning Date
  • NYT 08-06-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • NYT 1.26%
  • RGEN N/A
  • EPS Growth
  • NYT 21.26
  • RGEN N/A
  • EPS
  • NYT 1.83
  • RGEN N/A
  • Revenue
  • NYT $2,600,814,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • NYT $8.84
  • RGEN $13.93
  • Revenue Next Year
  • NYT $5.89
  • RGEN $14.35
  • P/E Ratio
  • NYT $31.20
  • RGEN N/A
  • Revenue Growth
  • NYT 6.90
  • RGEN 4.88
  • 52 Week Low
  • NYT $44.83
  • RGEN $102.97
  • 52 Week High
  • NYT $58.16
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • NYT 65.15
  • RGEN 54.11
  • Support Level
  • NYT $54.87
  • RGEN $121.44
  • Resistance Level
  • NYT $57.00
  • RGEN $131.43
  • Average True Range (ATR)
  • NYT 0.95
  • RGEN 4.47
  • MACD
  • NYT 0.09
  • RGEN 0.61
  • Stochastic Oscillator
  • NYT 97.26
  • RGEN 74.57

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: